17/06/2021 Volunteers
DRDO’S DRUG FOR COVID-19 The Drug Controller General of India (DCGI) certified 2-deoxy-d-glucose (2-DG) for emergency use in persons with moderate and severe COVID-19 on May 1 to support disease prevention. Researchers from the Institute of Nuclear Medicine and Allied Sciences, part of the Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories collaborated on this medicine
Covid-19 news
The Drug Controller General of India (DCGI) certified 2-deoxy-d-glucose (2-DG) for emergency use in persons with moderate and severe COVID-19 on May 1 to support disease prevention. Researchers from the Institute of Nuclear Medicine and Allied Sciences, part of the Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories collaborated on this medicine
DRDO’S DRUG FOR COVID-19 The Drug Controller General of India (DCGI) certified 2-deoxy-d-glucose (2-DG) for emergency use in persons with moderate and...
NEW DELHI: The disturbing ascent in day by day Covid-19 cases and passings in India proceeded on Wednesday even as the quantity of dynamic cases cross...
Brazil’s Sao Paulo-based Butantan Institute, a state-run clinical exploration office, on Wednesday started to produce ButanVac, the principal Brazilia...
COVID-19 has disrupted our lives and changed the world as we know it. For most people it has had dramatic consequences. Businesses are down. Everythin...
More Details